Taro Pharmaceuticals is recalling 971,667 bottles of Ibuprofen Oral Suspension (100 mg/5 mL) because small particles of inert plastic may have been introduced during the manufacturing process. The recall includes various sizes and formulations, such as 4-ounce and one-pint prescription bottles, and 4-ounce and 8-ounce berry-flavored children's versions sold under the Taro and Winco Foods brands. Consumers who have purchased these medications should check their lot numbers immediately and contact their healthcare provider or pharmacist for guidance if they have used the product.
The presence of foreign plastic particles in the liquid medication could lead to choking, irritation, or other internal injuries if swallowed. While the material is described as inert, its introduction into the medication poses a physical hazard to patients, especially children who may be more susceptible to airway obstruction or localized tissue irritation.
Contact healthcare provider and return to pharmacy for refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.